Pioneering
Digital Therapeutics

to transform chronic
disease management

Endorsement

ADA-01

Endorsement for our Type 2 Diabetes Therapeutic.
By South Asia's largest Diabetes association.

Recognitions

RSSDI-01

Global Thought Leader in Diabetes Care.
ADA 78th Scientific Sessions - Orlando, 2018.

IIHC

2019 Innovator cohort

Accelarators

SWISSRE

Graduated from Swiss Re's Global InsurTech Accelerator in 2017

SWISSRE

Graduated from ICICI Lombard's NOVA InsurTech Accelerator in 2017

SWISSRE

Graduated from Merck KGaA's Digital Health Accelerator in 2017

The Challenge

2 out of 3 indians die from poorly managed chronic health conditions which are aggravated by lifestyle and habits.

Wellthy designs clinically validated behavioral interventions to help people change their behaviors and reduce their risk of chronic disease.

Our Mission

To inspire and enable 10 million patients to reverse, prevent or control their chronic condition by 2025.

Wellthy
Meet a few members of our 100+ team.
Co-founding Team

Abhishek Shah, CEO

Prayat Shah, VP - Partnerships

Aradh Pillai, VP - Engineering and Design

Leadership Team

Anam R Dhila, VP - Finance

Tejas Bhatt, VP - Clinic and Hospital System

Vasim M Qureshi, VP - Care Delivery

Dr. Siddhesh Kolwankar, AVP - Clinical

Nikita Kewalramani, AVP - Content

Our Advisors

Dr. S R Arvind,

Leading Diabetologist,
RSSDI President 2016

Dr. Satish Garg

Leading Endocrinologist and Diabetes
Researcher Member of Scientific Chair,
American Diabetes Association

Mrs. Shilpa Joshi

Leading Dietitian and Diabetes Educator
Member, National Executive Committee
Indian Dietetic Association

Dr. Vinod Matto

Endocrinologist
Eli Lilly: Chief Scientific Officer
Bristol-Mayers Squibb: Medical Director